Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction

Background: Type 2 sodium-glucose cotransporter inhibitors (SGLT2i) are among the main therapeutic options for patients with chronic heart failure with reduced ejection fraction (HFrEF). The aim of this study was to evaluate the effects of SGLT2i on the echocardiographic parameters of left (LV) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcidi, Gianmarco, Pugliese, Rosanna, Ioannoni, Sara, Romano, Matteo, Palmieri, Gianpaolo, Tabella, Erika, Correale, Michele, Di Biase, Matteo, Brunetti, Natale Daniele, Iacoviello, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660544/
https://www.ncbi.nlm.nih.gov/pubmed/37987417
http://dx.doi.org/10.3390/clinpract13060116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660544/
https://www.ncbi.nlm.nih.gov/pubmed/37987417
http://dx.doi.org/10.3390/clinpract13060116

Ejemplares similares